0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial
Top Cited Papers
Open Access
- 2 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 24 (1), 1-10
- https://doi.org/10.1186/s13054-019-2683-3
Abstract
Acute kidney injury (AKI) is an important complication encountered during the course of diabetic ketoacidosis (DKA). Plasma-Lyte with lower chloride concentration than saline has been shown to be associated with reduced incidence of AKI in adults with septic shock. No study has compared this in DKA. This double-blind, parallel-arm, investigator-initiated, randomized controlled trial compared 0.9% saline with Plasma-Lyte-A as initial fluid in pediatric DKA. The study was done in a tertiary care, teaching, and referral hospital in India in children (> 1 month–12 years) with DKA as defined by ISPAD. Children with cerebral edema or known chronic kidney/liver disease or who had received pre-referral fluids and/or insulin were excluded. Sixty-six children were randomized to receive either Plasma-Lyte (n = 34) or 0.9% saline (n = 32). Primary outcome was incidence of new or progressive AKI, defined as a composite outcome of change in creatinine (defined by KDIGO), estimated creatinine clearance (defined by p-RIFLE), and NGAL levels. The secondary outcomes were resolution of AKI, time to resolution of DKA (pH > 7.3, bicarbonate> 15 mEq/L & normal sensorium), change in chloride, pH and bicarbonate levels, proportion of in-hospital all-cause mortality, need for renal replacement therapy (RRT), and length of ICU and hospital stay. Baseline characteristics were similar in both groups. The incidence of new or progressive AKI was similar in both [Plasma-Lyte 13 (38.2%) versus 0.9% saline 15 (46.9%); adjusted OR 1.22; 95% CI 0.43–3.43, p = 0.70]. The median (IQR) time to resolution of DKA in Plasma-Lyte-A and 0.9% saline were 14.5 (12 to 20) and 16 (8 to 20) h respectively. Time to resolution of AKI was similar in both [Plasma-Lyte 22.1 versus 0.9% saline 18.8 h (adjusted HR 1.72; 95% CI 0.83–3.57; p = 0.14)]. Length of hospital stay was also similar in both [Plasma-Lyte 9 (8 to 12) versus 0.9% saline 10 (8.25 to 11) days; p = 0.39]. The incidence of new or progressive AKI and resolution of AKI were similar in both groups. Plasma-Lyte-A was similar to 0.9% Saline in time to resolution of DKA, need for RRT, mortality, and lengths of PICU and hospital stay. Clinical trial registry of India, CTRI/2018/05/014042 (ctri.nic.in) (Retrospectively registered).Keywords
Funding Information
- Indian Council of Medical Research (3/2/Jan.2017/PG-Thesis-HRD (13))
This publication has 33 references indexed in Scilit:
- Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: a randomised double-blind pilot studyCritical Care, 2013
- Association Between a Chloride-Liberal vs Chloride-Restrictive Intravenous Fluid Administration Strategy and Kidney Injury in Critically Ill AdultsJAMA, 2012
- Nutritional status and complications in children with diabetic ketoacidosisPediatric Critical Care Medicine, 2012
- Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosisJournal of Critical Care, 2012
- Fluid management in diabetic-acidosis--Ringer's lactate versus normal saline: a randomized controlled trialQJM: An International Journal of Medicine, 2011
- Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosisThe American Journal of Emergency Medicine, 2011
- Bench-to-bedside review: Chloride in critical illnessCritical Care, 2010
- Diabetic ketoacidosis in children and adolescents with diabetesPediatric Diabetes, 2009
- Diabetic KetoacidosisTreatments in Endocrinology, 2003
- The risk and outcome of cerebral oedema developing during diabetic ketoacidosisArchives of Disease in Childhood, 2001